TrialJournal of bioenergetics and biomembranes2013

Case report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP.

Stephen B Strum et al.PubMed ↗Publisher ↗

No numbers read from the abstract.